Estimates Revisions Stereotaxis, Inc.
Stocks
STXS
US85916J4094
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
16:00:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 1.390 USD | +0.72% |
|
-3.47% | -39.57% |
| 08-11 | Stereotaxis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-11 | Stereotaxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- STXS Stock
- Consensus Stereotaxis, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
